Q-VAX Vaccine Now Available in the Netherlands for High-Risk Q Fever Patients

The Australian Q-VAX vaccine against Q fever is now accessible in the Netherlands.

Individuals with specific cardiovascular conditions face a higher risk of severe, prolonged illness from Q fever. Following advice from the Health Council, the government has made the vaccine available to this risk group. If you qualify and wish to be vaccinated, consult your general practitioner (GP). Your GP can register you at the Vaxinostics research and vaccination center.

The vaccine is offered to adults who:

• Have experienced heart inflammation (endocarditis);
• Have received a new heart valve (heart valve prosthesis);
• Have a congenital heart defect;
• Have issues with the aortic or mitral valve;
• Have an aneurysm (widening or bulging) of the aorta; or
• Have had part of the aorta replaced with a prosthetic graft.

The Health Council does not recommend vaccination for healthy individuals, those with other conditions, or people previously exposed to the Q fever bacteria.

Learn more about Q fever complications